Related Experiment Video
Updated: Aug 29, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence
David G Gilbert1, Yantao Zuo, Ronald A Browning
1Department of Psychology, Southern Illinois University at Carbondale, Carbondale, IL 62901-6502, USA. dgilbert@siu.edu
Abstract:
Although recent studies demonstrate that tobacco cigarette smoke substantially inhibits both central nervous system and blood platelet monoamine oxidase (MAO) activity, little is known about the time course of MAO increases after smoking cessation. Therefore, changes in platelet MAO-B activity and mood were assessed before and at multiple times after quitting smoking. Quitting smoking was associated with a significant (22%) increase in MAO activity by day 3 and with a maximum increase (about 50%) by day 10 that was maintained through day 31 of abstinence. However, abstinence-related increases in depressive mood peaked at day 2 of abstinence, a week more rapidly than the peak increase in MAO-B activity. Neither mood nor MAO-B activity returned to baseline or smoking control levels across the 31-day abstinence period. The asynchrony of increased negative affect and MAO-B activity during the first few days of abstinence may reflect any of several possibilities. First, the duration of the platelet life cycle may not reflect central MAO-B or MAO-A activity. Second, MAO-B may not contribute to or index mood changes during the first days of abstinence though it may contribute to protracted abstinence-induced negative affect. These findings are discussed in terms of the hypothesis that platelet MAO activity reflects central nervous system MAO changes that promote increased depressive affect resulting from smoking abstinence.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
